Telomir Pharmaceuticals Inc
TELO1.410USD
+0.040+2.92%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
47.70MMarket Cap
LossP/E TTM
Telomir Pharmaceuticals Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-0.56
-16.91%
Analyst Rating
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Telomir Pharmaceuticals Inc?
According to Telomir Pharmaceuticals Inc's FY2024 earnings report, its total revenue reached --, with a year-on-year change of --.
What is the Earnings Per Share (EPS) of Telomir Pharmaceuticals Inc?
According to Telomir Pharmaceuticals Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -0.560, with a year-on-year change of -16.91%.
What is the net income of Telomir Pharmaceuticals Inc?
According to Telomir Pharmaceuticals Inc's FY2024 earnings report, its net income was -16.53M, with a year-on-year change of -26.48%.
What is the net margin of Telomir Pharmaceuticals Inc?
According to Telomir Pharmaceuticals Inc's FY2024 earnings report, its net profit margin was --, with a year-on-year change of --.
What is the gross margin of Telomir Pharmaceuticals Inc?
According to Telomir Pharmaceuticals Inc's FY2024 earnings report, its gross margin was --, with a year-on-year change of --.
What is the debt-to-asset ratio of Telomir Pharmaceuticals Inc?
According to Telomir Pharmaceuticals Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Telomir Pharmaceuticals Inc?
According to Telomir Pharmaceuticals Inc's FY2024 earnings report, its Return on Equity (ROE) was -810.18%, with a year-on-year change of 22.50%.
What is the Return on Assets (ROA) of Telomir Pharmaceuticals Inc?
According to Telomir Pharmaceuticals Inc's FY2024 earnings report, its Return on Assets (ROA) was -542.25%, with a year-on-year change of -0.02%.
What is the operating profit of Telomir Pharmaceuticals Inc?
According to Telomir Pharmaceuticals Inc's FY2024 earnings report, its operating profit was -11.64M, with a year-on-year change of -195.33%.
What are the current assets of Telomir Pharmaceuticals Inc?
According to Telomir Pharmaceuticals Inc's FY2024 earnings report, its current assets were 1.32M, with a year-on-year change of 204.21%.
What are the total assets of Telomir Pharmaceuticals Inc?
According to Telomir Pharmaceuticals Inc's FY2024 earnings report, its total assets of Telomir Pharmaceuticals Inc were 1.32M, with a year-on-year change of -72.26%.
What are the total liabilities of Telomir Pharmaceuticals Inc?
According to Telomir Pharmaceuticals Inc's FY2024 earnings report, its total liabilities of Telomir Pharmaceuticals Inc were 680.97K, with a year-on-year change of -49.01%.
What is the total equity of Telomir Pharmaceuticals Inc?
According to Telomir Pharmaceuticals Inc's FY2024 earnings report, its total equity of Telomir Pharmaceuticals Inc was 643.04K, with a year-on-year change of -81.30%.
What is the net operating income of Telomir Pharmaceuticals Inc?
According to Telomir Pharmaceuticals Inc's FY2024 earnings report, its net operating income of Telomir Pharmaceuticals Inc was -16.53M, with a year-on-year change of -26.48%.
What is the net investment of Telomir Pharmaceuticals Inc?
According to Telomir Pharmaceuticals Inc's FY2024 earnings report, its net investment of Telomir Pharmaceuticals Inc was --, with a year-on-year change of --.
What is the net financing of Telomir Pharmaceuticals Inc?
According to Telomir Pharmaceuticals Inc's FY2024 earnings report, its net financing of Telomir Pharmaceuticals Inc was 6.34M, with a year-on-year change of 64.14%.
